Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Africa News Online.
Press releases published on June 23, 2025
Aster launches Hidden Orders: Invisible orders, visible advantage
GlobeNewswire
·
June 23, 2025
VICTORIA, Seychelles, June 23, 2025 (GLOBE NEWSWIRE) -- Aster, the next-generation decentralized perpetual exchange (perp DEX) backed by YZi Labs, proudly unveils its latest upgrade on Aster Pro: Hidden Orders. Hidden orders empower traders with powerful …
Ripplecoin Mining launches free cloud mining, allowing users to obtain stable cryptocurrency output through green energy networks
GlobeNewswire
·
June 23, 2025
San Francisco, California, June 23, 2025 (GLOBE NEWSWIRE) -- With major cryptocurrencies such as Bitcoin (BTC), Ripple (XRP) and Dogecoin (DOGE) experiencing price fluctuations recently, market risk aversion has increased. More and more users are turning …
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
GlobeNewswire
·
June 23, 2025
Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression Six-Month Patient Follow-up Results Demonstrate that Sana’s Transplanted Pancreatic Islet Cells Modified …
Earn Passive Income Daily: Ethransaction Launches Automated Cloud Mining for BTC, DOGE, and LTC
GlobeNewswire
·
June 23, 2025
London, UK, June 23, 2025 (GLOBE NEWSWIRE) -- New 2025 Upgrade Brings Accessible, Secure, and Automated Mining of BTC, DOGE, and LTC — No Hardware Needed In response to the growing enthusiasm for decentralized finance and blockchain-based applications, …
HashFly Debuts Smart and Profitable Cloud Mining Contract Model to Navigate Crypto Market Instability
GlobeNewswire
·
June 23, 2025
London, UK, June 23, 2025 (GLOBE NEWSWIRE) -- As crypto markets face mounting volatility in 2025, HashFly introduces a smart and profitable cloud mining solution to provide users with reliable earnings and adaptive performance. Amid heightened volatility …
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer with KRAS G12 Mutations
GlobeNewswire
·
June 23, 2025
Breakthrough Therapy Designation based on promising early clinical evidence observed with daraxonrasib in patients with pancreatic ductal adenocarcinoma (PDAC) RASolute 302, a Phase 3 registrational study of daraxonrasib in patients with previously treated …
PANA Holdings Chairman Takes Bold Step to Revolutionize Power Sector, Slash Nigeria’s Electricity Tariffs by 25%
EIN Presswire
·
June 23, 2025
Dr. Daere Akobo and PANA Infrastructure unveil bold plan to slash Nigeria’s electricity costs by up to 25% through smart infrastructure upgrades. ABUJA, NIGERIA, June 23, 2025 /EINPresswire.com/ -- In a decisive move to reshape Nigeria’s power sector, …
ALPHAMIN ANNOUNCES RESIGNATION OF DIRECTOR
GlobeNewswire
·
June 23, 2025
GRAND BAIE, MAURITIUS, June 23, 2025 (GLOBE NEWSWIRE) -- Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX) (the “Company” or “Alphamin”) announced today that Mr. Rudolf Pretorius has resigned as a director of the Company. Mr. Pretorius served as an …
Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
June 23, 2025
June 23, 2025 Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a …
Critical Metals Corp Signs Infill Diamond Drilling Program to Significantly Increase the Size of the Resource at Tanbreez
GlobeNewswire
·
June 23, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced it has signed a $2 million diamond drilling contract with renowned …
Ashvattha Therapeutics Reports the Ability to Tune Nanomedicines to Image Neuroinflammation in Multiple Sclerosis Patients and Tumor Associated Macrophages in Cancer at SNMMI Annual Meeting
GlobeNewswire
·
June 23, 2025
Novel nanomedicine radiotracer crosses blood brain barrier in patients with neuroinflammation Tumor macrophage radiotracer achieves 41.6% peak tumor uptake in preclinical studies REDWOOD CITY, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Ashvattha …
Vortex Energy Engages Caur Technologies and Storm Exploration for ANT Survey at Robinsons River Salt Project
GlobeNewswire
·
June 23, 2025
ANT SURVEY TO ENHANCE SUBSURFACE IMAGING AND ADVANCE HYDROGEN STORAGE POTENTIAL AT ROBINSONS RIVER VANCOUVER, British Columbia, June 23, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased …
Pan American Energy Announces Changes to Board of Directors
GlobeNewswire
·
June 23, 2025
CALGARY, Alberta, June 23, 2025 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (CSE: PNRG | OTCQB: PAANF | FRA: SS60) (“Pan American” or the “Company”), an exploration stage company engaged principally in the acquisition, exploration and development of …
ORYZON Announces Submission of Phase III Protocol to FDA to Initiate PORTICO-2 Trial of Vafidemstat in Borderline Personality Disorder (BPD) Patients
GlobeNewswire
·
June 23, 2025
PORTICO-2 designed to validate vafidemstat’s efficacy in reducing aggression in BPD patients Primary endpoint: STAXI-2 Trait Anger (patient-reported) Key secondary endpoint: Overt Aggression Scale-Modified (OAS-M) (clinician-rated) Additional secondary …
Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
GlobeNewswire
·
June 23, 2025
Vancouver, Canada, June 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
CorMedix inc. Announces Customer Implementation
GlobeNewswire
·
June 23, 2025
BERKELEY HEIGHTS, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces an update …
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
GlobeNewswire
·
June 23, 2025
MELBOURNE, Australia and INDIANAPOLIS, June 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved a label …
Aya Gold & Silver Closes Credit Facility with the EBRD to Support Boumadine Development
GlobeNewswire
·
June 23, 2025
MONTREAL, June 23, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Company”) is pleased to announce the closing of the previously announced US$25 million credit facility with the European Bank for Reconstruction and …
Goliath Intersects 6.31 g/t AuEq Over 14.35 Meters In RIRG Feeder Dyke, The First Of Multiple Relogged Holes Containing Abundant Visible Gold Substantially Expanding High-Grade Gold Potential On The Surebet Discovery That Remains Wide Open, Golddigger…
GlobeNewswire
·
June 23, 2025
Drill hole GD-22-64 assayed 6.31 g/t AuEq Over 14.35 Meters Including 11.36 g/t AuEq Over 7.85 Meters from a gold-rich intrusive feeder dyke and is the first of multiple drill holes containing gold visible to the naked eye over broad intervals identified …
ITM and Debiopharm Announce First Patient Imaged in New Study Arm of Phase 1/2 Trial Evaluating ITM-94 as Diagnostic Agent for Clear Cell Renal Cell Carcinoma (ccRCC)
GlobeNewswire
·
June 23, 2025
New study arm (Part D) is part of the broad clinical development plan of the ITM-91/ITM-94 theranostic program in patients with Carbonic Anhydrase IX (CAIX)-expressing tumors Part D builds on promising imaging data demonstrated in Part A of the study for …